These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34111467)

  • 1. The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis.
    McAlister E; Kirkby M; Domínguez-Robles J; Paredes AJ; Anjani QK; Moffatt K; Vora LK; Hutton ARJ; McKenna PE; Larrañeta E; Donnelly RF
    Adv Drug Deliv Rev; 2021 Aug; 175():113825. PubMed ID: 34111467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Painless drug delivery through microneedle-based transdermal patches featuring active infusion.
    Roxhed N; Samel B; Nordquist L; Griss P; Stemme G
    IEEE Trans Biomed Eng; 2008 Mar; 55(3):1063-71. PubMed ID: 18334398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedle - Future prospect for efficient drug delivery in diabetes management.
    Jana BA; Wadhwani AD
    Indian J Pharmacol; 2019; 51(1):4-10. PubMed ID: 31031461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in transdermal insulin delivery.
    Zhang Y; Yu J; Kahkoska AR; Wang J; Buse JB; Gu Z
    Adv Drug Deliv Rev; 2019 Jan; 139():51-70. PubMed ID: 30528729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
    Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
    Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin delivery systems combined with microneedle technology.
    Jin X; Zhu DD; Chen BZ; Ashfaq M; Guo XD
    Adv Drug Deliv Rev; 2018 Mar; 127():119-137. PubMed ID: 29604374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of microneedle array devices for continuous glucose monitoring: a review.
    El-Laboudi A; Oliver NS; Cass A; Johnston D
    Diabetes Technol Ther; 2013 Jan; 15(1):101-15. PubMed ID: 23234256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
    Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
    J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new paradigm for numerical simulation of microneedle-based drug delivery aided by histology of microneedle-pierced skin.
    Han T; Das DB
    J Pharm Sci; 2015 Jun; 104(6):1993-2007. PubMed ID: 25821048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success.
    Caffarel-Salvador E; Donnelly RF
    Curr Pharm Des; 2016; 22(9):1105-17. PubMed ID: 26675227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient safety and beyond: what should we expect from microneedle arrays in the transdermal delivery arena?
    Donnelly RF; Woolfson AD
    Ther Deliv; 2014 Jun; 5(6):653-62. PubMed ID: 25090279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Patchable Sensor Surveillance for Continuous Glucose Monitoring.
    Manasa G; Mascarenhas RJ; Shetti NP; Malode SJ; Mishra A; Basu S; Aminabhavi TM
    ACS Appl Bio Mater; 2022 Mar; 5(3):945-970. PubMed ID: 35170319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy.
    Zhang Y; Wu M; Tan D; Liu Q; Xia R; Chen M; Liu Y; Xue L; Lei Y
    J Mater Chem B; 2021 Jan; 9(3):648-657. PubMed ID: 33306077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart microneedle patches for rapid, and painless transdermal insulin delivery.
    Wang Y; Wang H; Zhu XX; Guan Y; Zhang Y
    J Mater Chem B; 2020 Oct; 8(40):9335-9342. PubMed ID: 32969458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
    Donnelly RF; Garland MJ; Alkilani AZ
    Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on microneedle-based systems for diabetes.
    Li WX; Zhang XP; Chen BZ; Fei WM; Cui Y; Zhang CY; Guo XD
    Drug Deliv Transl Res; 2022 Oct; 12(10):2275-2286. PubMed ID: 35112330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.
    Rini CJ; McVey E; Sutter D; Keith S; Kurth HJ; Nosek L; Kapitza C; Rebrin K; Hirsch L; Pettis RJ
    Drug Deliv Transl Res; 2015 Aug; 5(4):332-45. PubMed ID: 26037035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal insulin application system with dissolving microneedles.
    Ito Y; Nakahigashi T; Yoshimoto N; Ueda Y; Hamasaki N; Takada K
    Diabetes Technol Ther; 2012 Oct; 14(10):891-9. PubMed ID: 23013202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.
    Kirkby M; Hutton ARJ; Donnelly RF
    Pharm Res; 2020 Jun; 37(6):117. PubMed ID: 32488611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.